These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 304291)

  • 1. Effect of atenolol, a new cardioselective beta-blocker, on plasma renin activity in treatment of hypertension.
    Balansard P; Chabrillat Y; Paulin R; Libes M; Gérard R
    Acta Cardiol; 1977; 32(4):229-43. PubMed ID: 304291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atenolol administered once daily in primary hypertension. Effects on blood pressure in relation to pre-treatment plasma renin activity.
    Nilsson OR; Karlberg BE; Ohlsson O; Thulin T; Tolagen K
    Acta Med Scand; 1979; 206(4):303-8. PubMed ID: 506802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A dose ranging study of atenolol in hypertension: fall in blood pressure and plasma renin activity, beta-blockade and steady-state pharmacokinetics.
    Ishizaki T; Oyama Y; Suganuma T; Sasaki T; Nakaya H; Shibuya T; Sato T
    Br J Clin Pharmacol; 1983 Jul; 16(1):17-25. PubMed ID: 6349668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy and tolerability of a cardioselective beta-blocking drug (atenolol) in the treatment of essential hypertension. A double blind study (author's transl)].
    Rengo F; Trimarco B; Petretta M; Ferrara N; Bonaduce D; Chiariello M; Condorelli M
    G Ital Cardiol; 1978; 8(8):861-7. PubMed ID: 359398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The renin-angiotensin system and the antihypertensive effect of atenolol in man.
    Mimran A; Deschodt G; Fourcade J; Barjon P
    Arch Int Pharmacodyn Ther; 1979 Sep; 241(1):100-7. PubMed ID: 526065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of propranolol and atenolol on plasma renin activity and systolic time intervals in borderline hypertension.
    González-Gómez A; García-Barreto D; Gamio Capestany F; Hernández-Cañero A; Fong Chi S
    Cor Vasa; 1982; 24(6):422-8. PubMed ID: 6764167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term systemic hemodynamic adaptation to beta-adrenergic inhibition with atenolol in hypertensive patients.
    Simon G; Franciosa JA; Gimenez HJ; Cohn JN
    Hypertension; 1981; 3(2):262-8. PubMed ID: 6111532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of a beta 1-blocking agent, atenolol, on blood pressure, plasma renin activity and prostaglandin F2 alpha excretion in patients with essential hypertension.
    Pitkäjärvi T; Ylitalo P; Metsä-Ketelä T; Vapaatalo H
    Acta Med Scand; 1979; 206(1-2):107-13. PubMed ID: 484251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Haemodynamic response to antihypertensive treatment with atenolol in patients with hypertension (author's transl].
    Zilcher H; Glogar D; Uhlir H; Leisch F; Niederberger M; Steinbach K
    Wien Klin Wochenschr; 1978 Sep; 90(16):611-6. PubMed ID: 695651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the direct renin inhibitor aliskiren and atenolol alone or in combination in patients with hypertension.
    Dietz R; Dechend R; Yu CM; Bheda M; Ford J; Prescott MF; Keefe DL
    J Renin Angiotensin Aldosterone Syst; 2008 Sep; 9(3):163-75. PubMed ID: 18957387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antihypertensive and metabolic effects of increasing doses of atenolol and labetalol. A comparative study in primary hypertension.
    Nilsson OR; Karlberg BE; Henningsen NC; Thulin T
    Acta Med Scand Suppl; 1982; 665():117-9. PubMed ID: 6760679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Short term treatment of essential arterial hypertension with atenolol: effect on the renin-angiotensin-aldosterone system and on hemodynamic parameters].
    Indovina I; Salerno L; Licata G; Pepe S; Custro N
    Clin Ter; 1983 Feb; 104(3):223-6. PubMed ID: 6861459
    [No Abstract]   [Full Text] [Related]  

  • 13. Sympathetic responsiveness and antihypertensive effect of beta-receptor blockade in essential hypertension.
    Distler A; Keim HJ; Cordes U; Philipp T; Wolff HP
    Am J Med; 1978 Mar; 64(3):446-51. PubMed ID: 25017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute effect of atenolol on hemodynamic, plasma renin activity and plasma aldosterone concentration in the once daily oral administration.
    Sasaki Y; Arakawa K
    Jpn Circ J; 1984 Sep; 48(9):988-93. PubMed ID: 6384568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of atenolol in patients with renal impairment.
    Sassard J; Pozet N; McAinsh J; Legheand J; Zech P
    Eur J Clin Pharmacol; 1977 Nov; 12(3):175-80. PubMed ID: 590303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamics, biochemical and reflexive changes produced by atenolol in hypertension.
    Dreslinski GR; Messerli FH; Dunn FG; Suarez DH; Reisin E; Frohlich ED
    Circulation; 1982 Jun; 65(7):1365-8. PubMed ID: 6122514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Atenolol, a new beta-adrenergic blocking agent, in treatment of hypertension: therapeutic effect and hemodynamic changes (author's transl)].
    Shen JQ
    Zhonghua Xin Xue Guan Bing Za Zhi; 1981 Jun; 9(2):94-8. PubMed ID: 7032869
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of a vasodilating beta-blocker and a cardioselective beta-blocker in long-term treatment of hypertension: a European multicentre study.
    Ambrosioni E; Birkenhäger W; De Leeuw PW; Dal Palù C; Demanet JC; Groothold G; Libretti A; Mailland F; Malacco E; Poli A
    J Hypertens Suppl; 1989 Dec; 7(6):S266-7. PubMed ID: 2576667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of salbutamol, indomethacin and atenolol on plasma renin activity in patients with essential arterial hypertension].
    Stornello M; Di Rao G; Iachello M; Bosco V; Pantano S; Pisani R; Scapellato L
    Minerva Nefrol; 1982; 29(3):159-64. PubMed ID: 6292792
    [No Abstract]   [Full Text] [Related]  

  • 20. [Efficacy of a new beta-blocking drug (atenolol, ICI 66082) in treating arterial hypertension].
    Cerasola GA; Botta RM; Riolo A; Amico LM
    Boll Soc Ital Cardiol; 1979; 24(5):493-500. PubMed ID: 553637
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.